Trials & Tribulations Cancer AI systems: We need oncologists to help us build trusted models March 01, 2024Vol.50 No.09By Bernard Chien
Trials & Tribulations Florez Laboratory at Dana-Farber launches International Pregnancy and Lung Cancer Registry February 09, 2024Vol.50 No.06By Narjust Florez, Lauren Keil, Rebekah Kaufman and Oyepeju Abioye-Akintola
FreeTrials & Tribulations Engineering-level molecular diagnosis: A necessity for cancer treatment—and for a successful Moonshot July 21, 2023Vol.49 No.29By Michael P. Castro
Trials & Tribulations We need better communication to enable patients to thrive in cancer survivorship June 23, 2023Vol.49 No.25By Lauren Ghazal and Fumiko L. Chino
Trials & Tribulations Continuous temperature tracking helps manage infection risk after CAR T-cell therapy May 05, 2023Vol.49 No.18By Ruth Phillips
Trials & Tribulations San Antonio Breast Cancer Symposium 2022 tackled big obstacles, recommended solutions for breast cancer progress April 14, 2023Vol.49 No.15By Angela DeMichele, Rajarshi Sengupta and Carlos L. Arteaga
Trials & Tribulations Does salpingectomy prevent ovarian cancer? Let’s prove it.The SOROCk clinical trial, NRG CC008 (NCT04251052) March 17, 2023Vol.49 No.11By Kathryn P. Pennington, Warner K. Huh, Sandra Russo and Joan L. Walker
Trials & Tribulations MRI-guided radiotherapy for prostate cancer: Lessons from the MIRAGE trial February 03, 2023Vol.49 No.05By Amar U. Kishan
FreeTrials & Tribulations Ignore at your own risk: FDA draft guidance puts flashing lights around “dose optimization” January 27, 2023Vol.49 No.04By Mark J. Ratain and Garth W. Strohbehn
Trials & Tribulations Pancreatic cancer survival edges up—as screening strategies emerge January 20, 2023Vol.49 No.03By Rosario Ligresti
